Insulet (PODD) Capital Expenditures (2010 - 2026)
Insulet's (PODD) quarterly Capital Expenditures came in at $24.3 million in Q1 2026, up 97.56% YoY from $12.3 million in Q1 2025, and down 86.36% on a QoQ basis from $178.1 million in Q4 2025.
Insulet (PODD) Capital Expenditures (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Capital Expenditures data on file, last reported at $24.3 million in Q1 2026.
- Quarterly Capital Expenditures rose 97.56% year-over-year to $24.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.6 million (up 1313.89% YoY) and the FY2025 annual result came in at $191.6 million, up 2005.49% from the prior year.
- Capital Expenditures retreated to $24.3 million in Q1 2026, from $178.1 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $178.1 million in Q4 2025 to a low of -$62.2 million in Q4 2024.
- A 5-year average of $18.4 million and a median of $7.8 million in 2022 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 7950.0% in 2023, down 814.29% in 2023.
- Tracing PODD's Capital Expenditures over 5 years: stood at $2.5 million in 2022, then surged by 2676.0% to $69.4 million in 2023, then plunged by 189.63% to -$62.2 million in 2024, then jumped by 386.33% to $178.1 million in 2025, then slumped by 86.36% to $24.3 million in 2026.
- The last three Capital Expenditures figures came in at $24.3 million (Q1 2026), $178.1 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Insulet | 10.18 Bn | 9.64 Bn | 562.60 Mn | 32.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.50 Mn |
| Jun 30, 2026 | 32.50 Mn |
| Mar 31, 2026 | 24.30 Mn |
| Mar 31, 2026 | 24.30 Mn |
| Dec 31, 2025 | 178.10 Mn |
| Dec 31, 2025 | 178.10 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | -4.30 Mn |
| Jun 30, 2025 | -4.30 Mn |
| Mar 31, 2025 | 12.30 Mn |
| Mar 31, 2025 | 12.30 Mn |
| Dec 31, 2024 | -62.20 Mn |
| Dec 31, 2024 | -62.20 Mn |
| Sep 30, 2024 | 26.70 Mn |
| Sep 30, 2024 | 26.70 Mn |
| Jun 30, 2024 | 37.60 Mn |
| Jun 30, 2024 | 37.60 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Mar 31, 2024 | 7.00 Mn |